Goldman Sachs’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-365,000
| Closed | -$3.7M | – | 5184 |
|
|
2023
Q1 | $3.7M | Hold |
365,000
| – | – | ﹤0.01% | 2770 |
|
|
2022
Q4 | $3.63M | Hold |
365,000
| – | – | ﹤0.01% | 2873 |
|
|
2022
Q3 | $3.56M | Hold |
365,000
| – | – | ﹤0.01% | 2917 |
|
|
2022
Q2 | $3.54M | Hold |
365,000
| – | – | ﹤0.01% | 2971 |
|
|
2022
Q1 | $3.54M | Hold |
365,000
| – | – | ﹤0.01% | 3080 |
|
|
2021
Q4 | $3.53M | Hold |
365,000
| – | – | ﹤0.01% | 3079 |
|
|
2021
Q3 | $3.54M | Buy |
+365,000
| New | +$3.54M | ﹤0.01% | 3043 |
|